Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charles River Laboratories Intl. Inc (CRL) vs Rockwell Automation (ROK) Price & Performance

Charles River Laboratories Intl. IncTrade
Rockwell AutomationTrade

Price performance (Past 24H)

Key statistics

Charles River Laboratories Intl. Inc vs Rockwell Automation — how do they compare? Charles River Laboratories Intl. Inc trades at $303.01 (market cap $14.23B), while Rockwell Automation trades at $433.14 (market cap $48.21B). The key difference: Rockwell Automation is far larger — about 3.4× Charles River Laboratories Intl. Inc's market cap, and Rockwell Automation pays a 1.27% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Rockwell Automation for 74 Days on average.

CRLROK
Market Cap
$14.23B$48.21B
Volume
1,176,885953,342
Sector
HealthIndustrials
52-Week High
$310.77$495.08
52-Week Low
$149.93$333.75
Typical Hold Time
33 Days74 Days
Enterprise Value
$17.06B$51.34B
Dividend Yield
—1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Charles River Laboratories Intl. Inc

No Aura AI signal available yet.

Rockwell Automation

Rockwell Automation (ROK) trades at $432.61, down 2.1% on the day, with a bearish technical signal. The stock shows strong profitability with a 13.38% net income margin and 34.47% ROE, but trades at elevated valuation multiples including a P/E of 40.65. Recent earnings have consistently beaten estimates, and the company maintains a solid cash flow profile. Positive news highlights its leadership in industrial automation and digital transformation initiatives.

The outlook is mixed: analyst consensus is a Buy with a $489.89 price target, implying potential upside, but high valuation and near-term technical weakness pose risks. Key catalysts include continued execution on automation demand trends, while risks involve macroeconomic sensitivity and competitive pressures.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRL
0% Buy100% Sell
Avg holding period · 33 Days
ROK
0% Buy100% Sell
Avg holding period · 74 Days

Top news

Latest headlines on both assets

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL →

About Rockwell Automation

Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.

Read more on ROK →